From: Matthew Carruth Organization(s): U.S. Securities and Exchange Commission
Comment No: 26744 Date: 11/18/2010
Comment Text:
Conference call with Goldmans Sachs. Canonical representation for cleared-listed OTCs. Please see attachment.
